Manufacturing Systems and Controls STREAM
-
OsmoTECH XT Single-Sample Micro-Osmometer Demo
8/4/2021
This virtual presentation of the OsmoTECH XT demonstrates how easy the instrument is to use and explains its key features for osmolality measurement productivity and reliability.
-
Cell Insights By UmetricsĀ® Studio
12/2/2024
Cell Insights by Umetrics® Studio simplifies advanced data analytics for bioprocessing, offering hybrid modeling, virtual bioreactor simulations, and cell insights to streamline development, and support data-driven decisions.
-
Digitally Transforming Scientific Discovery, Research And Development
12/2/2024
Learn how Polar, a powerful cloud-based software platform, can optimize your data management, streamline processes, and reduce time to market.
-
Digital Backbone For Manufacturing And Process Quality Data
10/10/2023
When life sciences manufacturers rely on spreadsheets and paper records, it makes creating, gathering and sharing product and process data burdensome, expensive and prone to data integrity issues.
-
A Closed And Automated Solution For Cell Therapy Manufacturing
3/1/2024
Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.
-
A Tool To Support Your Everyday Analytical Needs
12/2/2024
Discover the impact of a cloud-based software platform with practical applications for instrument integration, bioreactor analysis, and more.
-
Pragmatic Computational Biology with Andrew Satz
9/20/2023
This week's guest on the Business of Biotech, EVQLV's Andrew Satz, says AI and ML in biopharma are like sex in high school. "Many of the people who say they're doing it really aren't, and the one who really are aren't talking about it," he says. So, when it comes to the computational biology buzz, what’s real? What’s hype? What’s yielding benefit and what’s merely vaporware?
-
CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt
10/25/2023
What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract development and manufacturing outsourcer (CDMO)? Jenny Holt, Chief Development Officer at the biopharma company Ray Therapeutics has some opinions. So does John Maslowski, Chief Commercial Officer at the CDMO Forge Biologics. Think they align?
-
Commercial Readiness with Orca Bio's Dan Kirby
9/14/2023
Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.
-
Multichannel Verification System And Assay Optimization Platform
4/30/2023
Learn how the Artel MVS can be used to rapidly troubleshoot and optimize the critical steps in your multi-step workflow, where liquid delivery volume is most important.